JP2015514779A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514779A5
JP2015514779A5 JP2015507175A JP2015507175A JP2015514779A5 JP 2015514779 A5 JP2015514779 A5 JP 2015514779A5 JP 2015507175 A JP2015507175 A JP 2015507175A JP 2015507175 A JP2015507175 A JP 2015507175A JP 2015514779 A5 JP2015514779 A5 JP 2015514779A5
Authority
JP
Japan
Prior art keywords
monohydrochloride
aqueous phase
anamorelin
manufacturing
anamorerin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015507175A
Other languages
English (en)
Japanese (ja)
Other versions
JP6109925B2 (ja
JP2015514779A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/037159 external-priority patent/WO2013158874A1/en
Publication of JP2015514779A publication Critical patent/JP2015514779A/ja
Publication of JP2015514779A5 publication Critical patent/JP2015514779A5/ja
Application granted granted Critical
Publication of JP6109925B2 publication Critical patent/JP6109925B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015507175A 2012-04-20 2013-04-18 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法 Active JP6109925B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636108P 2012-04-20 2012-04-20
US61/636,108 2012-04-20
PCT/US2013/037159 WO2013158874A1 (en) 2012-04-20 2013-04-18 Methods of producing anamorelin hydrochloride having controlled chloride content

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017043785A Division JP6284665B2 (ja) 2012-04-20 2017-03-08 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法

Publications (3)

Publication Number Publication Date
JP2015514779A JP2015514779A (ja) 2015-05-21
JP2015514779A5 true JP2015514779A5 (cg-RX-API-DMAC7.html) 2016-09-08
JP6109925B2 JP6109925B2 (ja) 2017-04-05

Family

ID=48225135

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015507175A Active JP6109925B2 (ja) 2012-04-20 2013-04-18 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法
JP2017043785A Active JP6284665B2 (ja) 2012-04-20 2017-03-08 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法
JP2018013782A Active JP6616853B2 (ja) 2012-04-20 2018-01-30 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017043785A Active JP6284665B2 (ja) 2012-04-20 2017-03-08 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法
JP2018013782A Active JP6616853B2 (ja) 2012-04-20 2018-01-30 制御された塩化物含量を有するアナモレリン塩酸塩の製造方法

Country Status (47)

Country Link
US (8) US20140018391A1 (cg-RX-API-DMAC7.html)
EP (3) EP2838892B1 (cg-RX-API-DMAC7.html)
JP (3) JP6109925B2 (cg-RX-API-DMAC7.html)
KR (2) KR101972998B1 (cg-RX-API-DMAC7.html)
CN (3) CN110041398A (cg-RX-API-DMAC7.html)
AP (1) AP2014008013A0 (cg-RX-API-DMAC7.html)
AR (1) AR090725A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013249197B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014025972A8 (cg-RX-API-DMAC7.html)
CA (2) CA3031652C (cg-RX-API-DMAC7.html)
CL (1) CL2014002817A1 (cg-RX-API-DMAC7.html)
CO (1) CO7131356A2 (cg-RX-API-DMAC7.html)
CR (1) CR20140530A (cg-RX-API-DMAC7.html)
CY (1) CY1120276T1 (cg-RX-API-DMAC7.html)
DK (2) DK2838892T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2014000235A (cg-RX-API-DMAC7.html)
EA (1) EA031581B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP14027739A (cg-RX-API-DMAC7.html)
ES (2) ES2820354T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20186902B (cg-RX-API-DMAC7.html)
HK (1) HK1248694A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20180316T1 (cg-RX-API-DMAC7.html)
HU (2) HUE050865T2 (cg-RX-API-DMAC7.html)
IL (1) IL235064B (cg-RX-API-DMAC7.html)
JO (1) JO3353B1 (cg-RX-API-DMAC7.html)
LT (1) LT2838892T (cg-RX-API-DMAC7.html)
MA (1) MA37524B1 (cg-RX-API-DMAC7.html)
MD (1) MD4615C1 (cg-RX-API-DMAC7.html)
ME (1) ME02966B (cg-RX-API-DMAC7.html)
MX (1) MX354793B (cg-RX-API-DMAC7.html)
MY (1) MY170068A (cg-RX-API-DMAC7.html)
NI (1) NI201400124A (cg-RX-API-DMAC7.html)
NO (1) NO2877697T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ700833A (cg-RX-API-DMAC7.html)
PE (1) PE20150084A1 (cg-RX-API-DMAC7.html)
PH (1) PH12014502351B1 (cg-RX-API-DMAC7.html)
PL (2) PL2838892T3 (cg-RX-API-DMAC7.html)
PT (2) PT2838892T (cg-RX-API-DMAC7.html)
RS (1) RS56869B1 (cg-RX-API-DMAC7.html)
SG (2) SG11201406478XA (cg-RX-API-DMAC7.html)
SI (2) SI2838892T1 (cg-RX-API-DMAC7.html)
TN (1) TN2014000421A1 (cg-RX-API-DMAC7.html)
TW (2) TWI677494B (cg-RX-API-DMAC7.html)
UA (1) UA116207C2 (cg-RX-API-DMAC7.html)
UY (1) UY34753A (cg-RX-API-DMAC7.html)
WO (1) WO2013158874A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201408508B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3353B1 (ar) 2012-04-20 2019-03-13 Ono Pharmaceutical Co شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي
HUE046894T2 (hu) 2014-09-04 2020-04-28 Helsinn Healthcare Sa Anamorelinen alapuló gyógyászati kezelések
CA2992016C (en) 2015-07-24 2019-10-22 Newlink Genetics Corporation Salts and prodrugs of 1-methyl-d-tryptophan
CN108239141A (zh) * 2016-12-23 2018-07-03 江苏先声药业有限公司 一种阿拉莫林的制备方法
CN115569119A (zh) * 2019-08-30 2023-01-06 赫尔森保健股份公司 具有改善稳定性的阿拉莫林片剂的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73530C2 (uk) * 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
CN1882526A (zh) * 2003-09-26 2006-12-20 兰贝克赛实验室有限公司 制备伏格列波糖的方法
EP1768976B1 (en) 2004-06-29 2017-04-26 Helsinn Healthcare S.A. Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
MX2009008561A (es) * 2007-02-13 2010-01-15 Helsinn Therapeutics Us Inc Metodo para tratar trastornos proliferativos celulares utilizando secretagogos.
UA105657C2 (uk) * 2009-02-27 2014-06-10 Хелсінн Терапьютікс (Ю.Ес.), Інк. Поліпшені способи лікування мігрені на основі анамореліну
JO3353B1 (ar) * 2012-04-20 2019-03-13 Ono Pharmaceutical Co شكل صلب معزول من أحادي هيدروكلوريد أناموريلين بنسبة مولارية منخفضة من الكلوريد: أناموريلين ومحتوى منخفض من مذيب عضوي متبقي

Similar Documents

Publication Publication Date Title
JP2015514779A5 (cg-RX-API-DMAC7.html)
JP2014512451A5 (cg-RX-API-DMAC7.html)
UA114497C2 (uk) Спосіб одержання карбонової кислоти
JP2014169319A5 (cg-RX-API-DMAC7.html)
JP2011126894A5 (cg-RX-API-DMAC7.html)
JP2013539448A5 (cg-RX-API-DMAC7.html)
MY171449A (en) Process for recovering permanganate reducing compounds from an acetic acid production process
JP2014518867A5 (cg-RX-API-DMAC7.html)
WO2013112884A3 (en) Method for purification of silicon
GB201210256D0 (en) Improved butanol recovery process
JP2016504328A5 (cg-RX-API-DMAC7.html)
IN2014MN02314A (cg-RX-API-DMAC7.html)
JP2011234359A5 (cg-RX-API-DMAC7.html)
WO2011081321A3 (ko) 레지스트 하층막용 조성물 및 이를 이용한 반도체 집적회로 디바이스의 제조방법
CN103965008A (zh) 一种用萃取精馏分离环己烷和乙酸乙酯混合物的方法
WO2015094530A3 (en) Process for making phenol and/or cyclohexanone
WO2014102834A3 (en) Process for lurasidone
MX2018015556A (es) Metodo para producir cristal de compuesto de uracilo.
WO2014173917A8 (en) Synthesis of bace inhibitors
CN103896834B (zh) 一种2‑氰基‑3‑环丁基吡啶及其化学合成方法
JP2012148965A5 (cg-RX-API-DMAC7.html)
JP2013133278A5 (ja) 発光素子用材料およびその合成方法
RU2014112315A (ru) Кристаллическая форма бромида тиотропия
WO2012116817A3 (en) Process for producing highly purified n-propanol
JP2015044990A5 (cg-RX-API-DMAC7.html)